Overview
Choroid plexus tumors (CPTs) are rare neoplasms arising from the choroid plexus epithelium, the tissue responsible for producing cerebrospinal fluid (CSF) within the ventricles of the brain. These tumors account for approximately 0.3–0.6% of all intracranial tumors and 2–4% of brain tumors in children. They are classified into three subtypes based on the World Health Organization (WHO) grading system: choroid plexus papilloma (WHO grade I, benign), atypical choroid plexus papilloma (WHO grade II, intermediate), and choroid plexus carcinoma (WHO grade III, malignant). The tumors predominantly occur in the lateral ventricles in children and in the fourth ventricle in adults. The primary clinical manifestation of choroid plexus tumors is hydrocephalus, caused by overproduction of CSF, obstruction of CSF flow, or impaired CSF absorption. This leads to symptoms of increased intracranial pressure, including headache, nausea, vomiting, irritability, lethargy, and in infants, rapid head enlargement (macrocephaly) and bulging fontanelles. Seizures, visual disturbances, and developmental delays may also occur. Choroid plexus carcinomas may invade surrounding brain tissue and, rarely, metastasize through the CSF pathways. Treatment typically involves surgical resection, which is the primary therapeutic approach and can be curative for choroid plexus papillomas when complete removal is achieved. For atypical papillomas and carcinomas, adjuvant chemotherapy and/or radiation therapy may be necessary, particularly when complete surgical excision is not possible or when there is evidence of dissemination. A subset of choroid plexus carcinomas has been associated with Li-Fraumeni syndrome caused by germline mutations in the TP53 gene, and genetic testing is recommended, especially in young children with choroid plexus carcinoma. Prognosis varies significantly by tumor grade, with choroid plexus papillomas having an excellent prognosis after complete resection, while choroid plexus carcinomas carry a more guarded outcome.
Sporadic
Usually appears on its own, not inherited from a parent
Variable
Can begin at different ages, from infancy through adulthood
Treatments
No FDA-approved treatments are currently listed for Choroid plexus tumor.
View clinical trials →Clinical Trials
View all trials with filters →No actively recruiting trials found for Choroid plexus tumor at this time.
New trials open frequently. Follow this disease to get notified.
Rare Disease Specialist
Treatment Centers
8 centersBaylor College of Medicine Rare Disease Center ↗
Baylor College of Medicine
📍 Houston, TX
🏥 NORDStanford Medicine Rare Disease Center ↗
Stanford Medicine
📍 Stanford, CA
🔬 UDNNIH Clinical Center Undiagnosed Diseases Program ↗
National Institutes of Health
📍 Bethesda, MD
🔬 UDNUCLA UDN Clinical Site ↗
UCLA Health
📍 Los Angeles, CA
🔬 UDNBaylor College of Medicine UDN Clinical Site ↗
Baylor College of Medicine
📍 Houston, TX
🔬 UDNHarvard/MGH UDN Clinical Site ↗
Massachusetts General Hospital
📍 Boston, MA
🏥 NORDMayo Clinic Center for Individualized Medicine ↗
Mayo Clinic
📍 Rochester, MN
👤 Mayo Clinic Center for Individualized Medicine
🏥 NORDUCLA Rare Disease Day Program ↗
UCLA Health
📍 Los Angeles, CA
Travel Grants
No travel grants are currently matched to Choroid plexus tumor.
Community
No community posts yet. Be the first to share your experience with Choroid plexus tumor.
Start the conversation →Latest news about Choroid plexus tumor
No recent news articles for Choroid plexus tumor.
Follow this condition to be notified when news becomes available.
Caregiver Resources
NORD Caregiver Resources
Support, advocacy, and financial assistance for caregivers of rare disease patients.
Mental Health Support
Rare disease caregiving can be isolating. Connect with counseling and peer support.
Family & Caregiver Grants
Financial assistance programs specifically for caregivers of rare disease patients.
Social Security Disability
Learn how rare disease patients may qualify for SSDI/SSI benefits.
Common questions about Choroid plexus tumor
What is Choroid plexus tumor?
Choroid plexus tumors (CPTs) are rare neoplasms arising from the choroid plexus epithelium, the tissue responsible for producing cerebrospinal fluid (CSF) within the ventricles of the brain. These tumors account for approximately 0.3–0.6% of all intracranial tumors and 2–4% of brain tumors in children. They are classified into three subtypes based on the World Health Organization (WHO) grading system: choroid plexus papilloma (WHO grade I, benign), atypical choroid plexus papilloma (WHO grade II, intermediate), and choroid plexus carcinoma (WHO grade III, malignant). The tumors predominantly o
How is Choroid plexus tumor inherited?
Choroid plexus tumor follows a sporadic inheritance pattern. Genetic counseling can help families understand recurrence risk and testing options.
Which specialists treat Choroid plexus tumor?
18 specialists and care centers treating Choroid plexus tumor are listed on UniteRare, sourced from ClinicalTrials.gov principal investigators, published research, and the NPPES NPI registry.